As a significantly high concentration of CHI3L1 is observed in the cerebrospinal fluid of Alzheimer’s patients, CHI3L1 could be considered as a biomarker for various diseases involving chronic inflammatory responses including AD [12,18,19,22,23]. The gene discussed is CHI3L1; the disease is Alzheimer disease.